Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy

[1]  E. Keeffe,et al.  Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case–control study , 2012, Cancer Causes & Control.

[2]  K. Madhavan,et al.  Value of alpha-foetoprotein for screening of recurrence in hepatocellular carcinoma post resection. , 2012, Singapore medical journal.

[3]  Shanshan Wang,et al.  Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma. , 2011, World journal of gastroenterology.

[4]  Yoshiyuki Suzuki,et al.  Highly sensitive AFP‐L3% assay is useful for predicting recurrence of hepatocellular carcinoma after curative treatment pre‐ and postoperatively , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

[5]  Hui-Xiong Xu,et al.  [Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors]. , 2011, Zhonghua yi xue za zhi.

[6]  Wen-fang Xu,et al.  [Significance of serum golgi protein 73 (GP73), alpha-fetoprotein (AFP) and lectin-reactive alpha-fetoprotein (AFP-L3) expresssion in primary hepatic carcinoma]. , 2011, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology.

[7]  N. Xu,et al.  Clinical application of determining serum AFP-IgM complexes for diagnosis of small hepatocellular carcinoma. , 2011, Anticancer research.

[8]  H. Imamura,et al.  AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC , 2010, Journal of Gastroenterology.

[9]  G. Narayanan,et al.  Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era. , 2010, Journal of the American College of Surgeons.

[10]  Qiang Li,et al.  [Influencing factors for intrahepatic distant recurrence of liver cancer after radiofrequency ablation]. , 2009, Zhonghua wai ke za zhi [Chinese journal of surgery].

[11]  I. Sultana,et al.  Hepatocellular carcinoma (HCC) and diagnostic significance of A-fetoprotein (AFP). , 2009, Journal of Ayub Medical College, Abbottabad : JAMC.

[12]  J. Kao,et al.  Factors Associated with Progression to Hepatocellular Carcinoma and to Death from Liver Complications in Patients with HBsAg-Positive Cirrhosis , 2009, Digestive Diseases and Sciences.

[13]  T. Mok,et al.  New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  M. Omata,et al.  Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review , 2008, Hepatology international.

[15]  Ruan You-bing,et al.  The comparative study on ultrastructure and immunohistochemistry in AFP negative and positive hepatocellular carcinoma , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].

[16]  G. Klintmalm,et al.  Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis , 2007, Alimentary pharmacology & therapeutics.

[17]  B. Koneru,et al.  Hepatitis status, child-pugh classification, and serum AFP levels predict survival in patients treated with transarterial embolization for unresectable hepatocellular carcinoma , 2005, Journal of Gastrointestinal Surgery.

[18]  J. Marrero,et al.  Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. , 2007, Cancer biomarkers : section A of Disease markers.

[19]  Xiao-li Feng,et al.  Tight association of hepatocellular carcinoma with HBV infection in North China. , 2005, Hepatobiliary & pancreatic diseases international : HBPD INT.

[20]  M. Makuuchi,et al.  Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey , 2004, Cancer.

[21]  Jae-Hoon Jung,et al.  [Clinical significance of transiently elevated serum AFP level in developing hepatocellular carcinoma in HBsAg positive-liver cirrhosis]. , 2004, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[22]  L. Qin,et al.  The prognostic significance of clinical and pathological features in hepatocellular carcinoma. , 2002, World journal of gastroenterology.

[23]  P. Tangkijvanich,et al.  Clinical Characteristics and Prognosis of Hepatocellular Carcinoma: Analysis Based on Serum Alpha-fetoprotein Levels , 2000, Journal of clinical gastroenterology.

[24]  P. Johnson.  Role of alpha‐fetoprotein in the diagnosis and management of hepatocellular carcinoma , 1999, Journal of gastroenterology and hepatology.

[25]  P. Kandasami,et al.  Optimal treatment for duodenal ulcer disease: A cost–decision analysis in Malaysian patients , 1999, Journal of gastroenterology and hepatology.